Profile change history

What changed for Ganirelix?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Ganirelix identity.

42Total events
42Record additions
0Version changes
17Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 42 connected records →

Showing the latest 42 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 15, 2026.

Record added

ClinicalTrials.gov record NCT00225433

PeptideScanner retained ClinicalTrials.gov record NCT00225433 at 2026-11-15T22:03:26.540Z. Its registry update date was 2015-12-03, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
December 3, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00461422

PeptideScanner retained ClinicalTrials.gov record NCT00461422 at 2026-11-15T22:03:26.540Z. Its registry update date was 2008-06-27, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
June 27, 2008
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00589134

PeptideScanner retained ClinicalTrials.gov record NCT00589134 at 2026-11-15T22:03:26.540Z. Its registry update date was 2020-03-30, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
March 30, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00608062

PeptideScanner retained ClinicalTrials.gov record NCT00608062 at 2026-11-15T22:03:26.540Z. Its registry update date was 2020-12-24, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
December 24, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00696800

PeptideScanner retained ClinicalTrials.gov record NCT00696800 at 2026-11-15T22:03:26.540Z. Its registry update date was 2024-06-20, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
June 20, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00702273

PeptideScanner retained ClinicalTrials.gov record NCT00702273 at 2026-11-15T22:03:26.540Z. Its registry update date was 2024-09-05, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
September 5, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00703014

PeptideScanner retained ClinicalTrials.gov record NCT00703014 at 2026-11-15T22:03:26.540Z. Its registry update date was 2024-09-19, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
September 19, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00724789

PeptideScanner retained ClinicalTrials.gov record NCT00724789 at 2026-11-15T22:03:26.540Z. Its registry update date was 2022-02-03, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
February 3, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00734279

PeptideScanner retained ClinicalTrials.gov record NCT00734279 at 2026-11-15T22:03:26.540Z. Its registry update date was 2017-12-26, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
December 26, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00757185

PeptideScanner retained ClinicalTrials.gov record NCT00757185 at 2026-11-15T22:03:26.540Z. Its registry update date was 2016-07-04, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
July 4, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00780858

PeptideScanner retained ClinicalTrials.gov record NCT00780858 at 2026-11-15T22:03:26.540Z. Its registry update date was 2015-05-06, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
May 6, 2015
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00802360

PeptideScanner retained ClinicalTrials.gov record NCT00802360 at 2026-11-15T22:03:26.540Z. Its registry update date was 2011-11-02, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
November 2, 2011
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00823004

PeptideScanner retained ClinicalTrials.gov record NCT00823004 at 2026-11-15T22:03:26.540Z. Its registry update date was 2013-12-23, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
December 23, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT00988260

PeptideScanner retained ClinicalTrials.gov record NCT00988260 at 2026-11-15T22:03:26.540Z. Its registry update date was 2024-08-15, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
August 15, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01153581

PeptideScanner retained ClinicalTrials.gov record NCT01153581 at 2026-11-15T22:03:26.540Z. Its registry update date was 2018-12-13, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
December 13, 2018
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01286051

PeptideScanner retained ClinicalTrials.gov record NCT01286051 at 2026-11-15T22:03:26.540Z. Its registry update date was 2013-03-20, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
March 20, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01304511

PeptideScanner retained ClinicalTrials.gov record NCT01304511 at 2026-11-15T22:03:26.540Z. Its registry update date was 2024-04-03, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
April 3, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01645241

PeptideScanner retained ClinicalTrials.gov record NCT01645241 at 2026-11-15T22:03:26.540Z. Its registry update date was 2014-10-27, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
October 27, 2014
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01816321

PeptideScanner retained ClinicalTrials.gov record NCT01816321 at 2026-11-15T22:03:26.540Z. Its registry update date was 2016-06-23, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
June 23, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03051087

PeptideScanner retained ClinicalTrials.gov record NCT03051087 at 2026-11-15T22:03:26.540Z. Its registry update date was 2019-07-02, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
July 2, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03142893

PeptideScanner retained ClinicalTrials.gov record NCT03142893 at 2026-11-15T22:03:26.540Z. Its registry update date was 2025-09-11, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
September 11, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT03300518

PeptideScanner retained ClinicalTrials.gov record NCT03300518 at 2026-11-15T22:03:26.540Z. Its registry update date was 2022-01-11, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
January 11, 2022
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04037605

PeptideScanner retained ClinicalTrials.gov record NCT04037605 at 2026-11-15T22:03:26.540Z. Its registry update date was 2025-09-11, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
September 11, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05751252

PeptideScanner retained ClinicalTrials.gov record NCT05751252 at 2026-11-15T22:03:26.540Z. Its registry update date was 2025-04-27, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
April 27, 2025
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05954962

PeptideScanner retained ClinicalTrials.gov record NCT05954962 at 2026-11-15T22:03:26.540Z. Its registry update date was 2026-03-27, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
March 27, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06091436

PeptideScanner retained ClinicalTrials.gov record NCT06091436 at 2026-11-15T22:03:26.540Z. Its registry update date was 2024-12-03, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
December 3, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT06745466

PeptideScanner retained ClinicalTrials.gov record NCT06745466 at 2026-11-15T22:03:26.540Z. Its registry update date was 2026-07-02, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
July 2, 2026
Evidence lane
Clinical trials
Record added

Federal Register notice 04-24378

The Federal Register published notice 04-24378, attributed to FDA and its parent HHS department, on 2004-11-02. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; GANIRELIX ACETATE INJECTION (Formerly ANTAGON),” and PeptideScanner's exact reviewed identity mapping connects the document to Ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
November 2, 2004
Evidence lane
Regulatory
Record added

Ganirelix acetate.

PubMed lists PMID 10582819 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 1999-11-15 (day precision). PeptideScanner associated the retained record with the identity slug ganirelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
February 21, 2019
Evidence lane
Literature metadata
Record added

Ganirelix.

PubMed lists PMID 10718102 in Drugs as Journal Article, Review, with publication-date metadata of 2000-01 (month precision). PeptideScanner associated the retained record with the identity slug ganirelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 13, 2018
Evidence lane
Literature metadata
Record added

Ganirelix for luteolysis in poor responder patients undergoing IVF treatment: a Scandinavian multicenter 'extended pilot study'.

PubMed lists PMID 20504085 in Acta obstetricia et gynecologica Scandinavica as Journal Article, Multicenter Study, with publication-date metadata of 2010-06 (month precision). PeptideScanner associated the retained record with the identity slug ganirelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 25, 2016
Evidence lane
Literature metadata
Record added

Molecular characterization, modeling, in silico analysis of equine pituitary gonadotropin alpha subunit and docking interaction studies with ganirelix.

PubMed lists PMID 28721542 in In silico pharmacology as Journal Article, with publication-date metadata of 2017-07-18 (day precision). PeptideScanner associated the retained record with the identity slug ganirelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
March 26, 2024
Evidence lane
Literature metadata
Record added

New local ganirelix sustained release therapy for uterine leiomyoma. Evaluation in a preclinical organ model.

PubMed lists PMID 36279721 in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie as Journal Article, with publication-date metadata of 2022-10-21 (day precision). PeptideScanner associated the retained record with the identity slug ganirelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 27, 2026
Evidence lane
Literature metadata
Record added

Radioimmunoassay of ganirelix in plasma or serum.

PubMed lists PMID 8354719 in Journal of immunoassay as Comparative Study, Journal Article, with publication-date metadata of 1993-09 (month precision). PeptideScanner associated the retained record with the identity slug ganirelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
November 1, 2019
Evidence lane
Literature metadata